Pregnant women can breathe a sigh of relief: a comprehensive study has confirmed that taking paracetamol during pregnancy does not increase the risk of autism or ADHD in children. This major finding, published in The Lancet Obstetrics, Gynaecology & Women’s Health, addresses long-standing concerns and provides clarity for expectant mothers. The research, conducted by an international team of experts, analyzed decades of global data, focusing on sibling comparison studies to account for shared genetic and environmental factors. The results are a significant reassurance for women who have been anxious about the safety of paracetamol during pregnancy.
The study, led by researchers from the University of London and UK NHS hospitals, examined 43 existing studies, prioritizing high-quality research with robust methods. By comparing siblings born to the same mother, where one pregnancy involved paracetamol use and the other did not, the researchers were able to isolate the effects of paracetamol from other factors that can influence child development. The findings were clear: there was no increased risk of autism, ADHD, or intellectual disability in children whose mothers took paracetamol during pregnancy.
This large-scale analysis directly counters recent high-profile claims in the US that suggested a possible link between paracetamol and neurodevelopmental disorders. The researchers concluded that earlier studies, which reported small associations, were often based on weaker study designs and did not fully account for factors such as maternal illness, fever, family history, or genetics. By focusing on sibling comparisons and excluding lower-quality evidence, the researchers determined that the earlier links were likely due to bias or unmeasured confounding, rather than a true causal effect of paracetamol.
Paracetamol is the most commonly recommended painkiller during pregnancy in the UK, and it is widely used to treat headaches, pain, and fever. It is generally considered safer than alternatives such as ibuprofen or opioid painkillers. Doctors emphasize that untreated fever or severe pain during pregnancy can pose risks, including preterm birth and other complications. Avoiding paracetamol unnecessarily could therefore do more harm than good.
The findings support existing advice from the NHS, the Medicines and Healthcare products Regulatory Agency, and the Royal College of Obstetricians and Gynaecologists, all of which continue to recommend paracetamol as the first-line option in pregnancy when used at the lowest effective dose. The study also comes at a time when there is ongoing debate in the US, where claims about Tylenol (the US brand name for paracetamol) have been linked to wider misinformation about autism. Responding to these claims, experts have warned about the real-world impact of spreading fear among expectant parents, emphasizing that painkillers do not cause autism and that large-scale studies have shown no robust, scientific evidence to support such claims.
For pregnant women, the message is clear: taking paracetamol as advised during pregnancy is not linked to autism, ADHD, or intellectual disability. Health experts continue to recommend it as a safe and effective option for pain and fever relief. If women are ever unsure about medication in pregnancy, it is always best to speak to their GP or midwife, but this study offers strong reassurance at a time when many expectant mothers have been left feeling anxious and confused.
